Kurma Partners Closes €215M Fund for Disruptive Therapeutics
Kurma Partners Scales Biotech Ambitions with Landmark €215M Venture Fund PARIS — In a decisive move to reshape the landscape of European medicine, VC firm Kurma Partners has officially closed a €215 million fund aimed at accelerating the development of transformative healthcare treatments. This new vehicle represents the firm’s fourth fund and stands as its … Read more